Getting Personal Perspectives on Individualized Treatment Duration in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis-Reference-Cited by-同舟云学术

Getting Personal Perspectives on Individualized Treatment Duration in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

Published:2014-08-15 Issue:4 Volume:190 Page:374-383
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Heyckendorf Jan,Olaru Ioana D.,Ruhwald Morten,Lange Christoph

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference100 articles.

1. World Health Organizaton. WHO global tuberculosis report 2013. Geneva, Switzerland: World Health Organization; 2013.

2. World Health Organizaton. Guidelines for the programmatic management of drug-resistant tuberculosis 2011 update. Geneva, Switzerland: World Health Organization; 2011.

3. Strategies for Reduction in Duration of Antibiotic Use in Hospitalized Patients

4. Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients

5. Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New coumarin linked thiazole derivatives as antimycobacterial agents: Design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling;Bioorganic Chemistry;2024-09

2. Clinical utilization of artificial intelligence in predicting therapeutic efficacy in pulmonary tuberculosis;Journal of Infection and Public Health;2024-04

3. Isatin-pyrimidine hybrid derivatives as enoyl acyl carrier protein reductase (InhA) inhibitors against Mycobacterium tuberculosis;Bioorganic Chemistry;2023-09

4. Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies;Clinical Microbiology Reviews;2022-09-21

5. Biosafety materials for tuberculosis treatment;Biosafety and Health;2022-08